Showing results (1271-1280 of 1,350) with videos related to
Sort By:
Pageof 135
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 2, 2015
A randomized, multicenter, phase II/III study to determine the optimal dose and to evaluate the efficacy and safety of pegteograstim (GCPGC) on chemotherapy-induced neutropenia compared to pegfilgrastim in breast cancer patients: KCSG PC10-09Ki Hyeong Lee, Ji-Yeon Kim, Moon Hee Lee, et al.Seminars in Arthritis and Rheumatism|April 3, 2012
Do patients with elderly-onset rheumatoid arthritis have severe functional disability?Soo-Kyung Cho, Yoon-Kyoung Sung, Chan-Bum Choi, et al.Rheumatology International|July 28, 2017
Impact of interstitial lung disease on mortality of patients with rheumatoid arthritisDam Kim, Soo-Kyung Cho, Chan-Bum Choi, et al.The Journal of Biological Chemistry|January 29, 2016
Self-assembled Micelle Interfering RNA for Effective and Safe Targeting of Dysregulated Genes in Pulmonary FibrosisPyoung Oh Yoon, Jin Wook Park, Chang-Min Lee, et al.Lung Cancer (Amsterdam, Netherlands)|August 27, 2019
Safety, tolerability, and anti-tumor activity of olmutinib in non-small cell lung cancer with T790M mutation: A single arm, open label, phase 1/2 trialDong-Wan Kim, Dae Ho Lee, Ji-Youn Han, et al.Clinical Cardiology|July 2, 2009
Two-year outcomes of the sirolimus-eluting stent according to unprotected left main lesionUng Kim, Jong-Seon Park, Sang-Hoon Seol, et al.Journal of Korean Medical Science|June 2, 2010
The causative organisms of bacterial meningitis in Korean children in 1996-2005Hye Kyung Cho, Hyunju Lee, Jin Han Kang, et al.Cancer Research and Treatment|August 5, 2016
Feasibility and Efficacy of Eribulin Mesilate in Korean Patients with Metastatic Breast Cancer: Korean Multi-center Phase IV Clinical Study ResultsYeon Hee Park, Tae Yong Kim, Young-Hyuck Im, et al.Cancer Research and Treatment|September 14, 2016
An Open-Label, Randomized, Parallel, Phase III Trial Evaluating the Efficacy and Safety of Polymeric Micelle-Formulated Paclitaxel Compared to Conventional Cremophor EL-Based Paclitaxel for Recurrent or Metastatic HER2-Negative Breast CancerIn Hae Park, Joo Hyuk Sohn, Sung Bae Kim, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2017
Open-Label, Multicenter, Phase II Study of Ceritinib in Patients With Non-Small-Cell Lung Cancer Harboring ROS1 RearrangementSun Min Lim, Hye Ryun Kim, Jong-Seok Lee, et al.Pageof 135